Versor Investments LP

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 1650301 New York, NY

Position in CPRX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$0

New position

Shares Held

76,286

first reported quarter

Ownership

0.062%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Versor Investments LP holds $5,389,438 across 4 Biotechnology names. CPRX ranks #3 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	42,050	$2,970,832
2	APGE	Apogee Therapeutics, Inc.	18,222	$2,418,606
3	CPRX	Catalyst Pharmaceuticals, Inc. This page	76,286	$0
4	NUVL	Nuvalent, Inc.	25,850	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	—	76,286	—	Shares	Sole	2026-08-07
No filing history on record for this holder in this stock.